ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $925,000 | -2.2% | 700,421 | 0.0% | 0.23% | +26.6% |
| Q4 2021 | $946,000 | -53.6% | 700,421 | 0.0% | 0.18% | -42.5% |
| Q3 2021 | $2,038,000 | -16.6% | 700,421 | 0.0% | 0.32% | +6.0% |
| Q2 2021 | $2,444,000 | +2.0% | 700,421 | 0.0% | 0.30% | -31.7% |
| Q1 2021 | $2,395,000 | -84.7% | 700,421 | -14.1% | 0.44% | -71.9% |
| Q4 2020 | $15,656,000 | +43.0% | 815,421 | 0.0% | 1.57% | -48.5% |
| Q3 2020 | $10,951,000 | -47.9% | 815,421 | +64.2% | 3.06% | -54.8% |
| Q2 2020 | $21,022,000 | +45.7% | 496,505 | -5.0% | 6.76% | -18.6% |
| Q1 2020 | $14,430,000 | -14.9% | 522,637 | 0.0% | 8.30% | +2.2% |
| Q4 2019 | $16,960,000 | +24.7% | 522,637 | 0.0% | 8.13% | -12.2% |
| Q3 2019 | $13,604,000 | -39.8% | 522,637 | -15.1% | 9.26% | -38.0% |
| Q2 2019 | $22,596,000 | +71.5% | 615,850 | +3.4% | 14.93% | +44.2% |
| Q1 2019 | $13,174,000 | +57.0% | 595,850 | 0.0% | 10.35% | +28.6% |
| Q4 2018 | $8,390,000 | – | 595,850 | – | 8.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 14,075,269 | $595,947,000 | 57.94% |
| Samsara BioCapital, LLC | 496,505 | $21,022,000 | 6.76% |
| Boxer Capital, LLC | 3,363,377 | $142,405,000 | 6.26% |
| Opaleye Management Inc. | 250,000 | $10,585,000 | 2.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 785,913 | $33,276,000 | 0.81% |
| RTW INVESTMENTS, LP | 481,027 | $20,367,000 | 0.57% |
| Birchview Capital, LP | 20,000 | $847,000 | 0.51% |
| Rock Springs Capital Management LP | 437,231 | $18,512,000 | 0.51% |
| Redmile Group, LLC | 633,038 | $26,803,000 | 0.50% |
| SABBY MANAGEMENT, LLC | 40,500 | $1,715,000 | 0.34% |